{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:54:03Z","timestamp":1792803243977,"version":"4.5.0"},"reference-count":132,"publisher":"Informa UK Limited","issue":"7","funder":[{"name":"Riley Children\u2019s Foundation and NIH","award":["CA121168, CA167291"],"award-info":[{"award-number":["CA121168, CA167291"]}],"id":[{"id":"https:\/\/ror.org\/03sabpy05","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.2217\/fon.14.60","type":"journal-article","created":{"date-parts":[[2014,6,20]],"date-time":"2014-06-20T07:00:22Z","timestamp":1403247622000},"page":"1215-1237","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":175,"title":["Targeting DNA Repair Pathways for Cancer Treatment: what\u2019s new?"],"prefix":"10.1080","volume":"10","author":[{"given":"Mark R","family":"Kelley","sequence":"first","affiliation":[{"name":"Department of Pediatrics,Herman B Wells Center for Pediatric Research,Indiana University School of Medicine,\r          Indianapolis,\r          IN,\r          USA"},{"name":"Department of Pharmacology & Toxicology,Indiana University School of Medicine,\r          Indianapolis,\r          IN,\r          USA"},{"name":"Department of Biochemistry & Molecular Biology,Indiana University School of Medicine,\r          Indianapolis,\r          IN,\r          USA"},{"name":"Herman B Wells Center for Pediatric Research,\r          1044 W. Walnut Street, R4-302\r          Indianapolis,\r          IN\r          46202,\r          USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Logsdon","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Toxicology,Indiana University School of Medicine,\r          Indianapolis,\r          IN,\r          USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa L","family":"Fishel","sequence":"additional","affiliation":[{"name":"Department of Pediatrics,Herman B Wells Center for Pediatric Research,Indiana University School of Medicine,\r          Indianapolis,\r          IN,\r          USA"},{"name":"Department of Pharmacology & Toxicology,Indiana University School of Medicine,\r          Indianapolis,\r          IN,\r          USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,6,20]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/gm99"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2008.2218"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-0984"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2009.2698"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2007.03.008"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-6615-5_7"},{"key":"e_1_3_2_9_1","unstructured":"De Lartigue J . New life for PARP inhibitors: emerging agents leave mark at ASCO . www.onclive.com\/publications\/oncology-live\/2013\/august-2013\/new-life-for-parp-inhibitors-emerging-agents-leave-mark-at-asco\/4"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature03443"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq322"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2010.00240"},{"key":"e_1_3_2_13_1","unstructured":"ClinicalTrials.gov . https:\/\/clinicaltrials.gov"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1011418"},{"key":"e_1_3_2_15_1","unstructured":"De Lartigue J . The PARP inhibitors: down but not out (2012) . www.onclive.com\/publications\/oncology-live\/2012\/july-2012\/the-parp-inhibitors-down-but-not-out\/2"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0511-373"},{"issue":"290","key":"e_1_3_2_17_1","first-page":"1","article-title":"Beyond DNA repair: additional functions of PARP-1 in cancer","volume":"3","author":"Weaver AN","year":"2013","unstructured":"Weaver AN , YangES . Beyond DNA repair: additional functions of PARP-1 in cancer . Front. Oncol.3 ( 290 ), 1 \u2013 11 ( 2013 ).","journal-title":"Front. Oncol."},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2013.768615"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2812"},{"key":"e_1_3_2_20_1","unstructured":"AZD2461 ( 2013 ). www.selleckchem.com\/products\/azd2461.html"},{"key":"e_1_3_2_21_1","unstructured":"Newswire G . BioMarin provides updated Phase 1\/2 data on BMN 673 in breast cancer at the european cancer congress 2013 . 1 1 ( 2013 ). www.marketwatch.com\/story\/biomarin-provides-updated-phase-12-data-on-bmn-673-in-breast-cancer-at-the-european-cancer-congress-2013-2013-09-29"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-2753"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2013.10.005"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.388"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.4161\/cc.11.6.19576"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djq294"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-09-0519"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.071316"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1319"},{"key":"e_1_3_2_30_1","first-page":"566","volume-title":"Principles of Molecular Diagnostics and Personalized Cancer Medicine.","author":"Kelley MR","year":"2013","unstructured":"Kelley MR , FishelML . DNA Repair and Cancer Therapeutics . In:Principles of Molecular Diagnostics and Personalized Cancer Medicine.TanD , LynchHT (Eds). Lippincott Williams & Wilkins , PA, USA , 566 \u2013 579 ( 2013 )."},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2006.10.008"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-009-8736-z"},{"key":"e_1_3_2_33_1","first-page":"233","volume-title":"DNA Repair and Cancer: From Bench to Clinic.","author":"Fishel ML","year":"2013","unstructured":"Fishel ML , VascottoC , KelleyMR . DNA base excision repair therapeutics: summary of targets with a focus on APE1 . In:DNA Repair and Cancer: From Bench to Clinic.MadhusudanS , WilsonDM (Eds). CRC Press , FL, USA , 233 \u2013 287 ( 2013 )."},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-012-0887-x"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.12.58"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.2174\/1874467211205010036"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016691"},{"key":"e_1_3_2_38_1","unstructured":"Rai G VyjayantiVN DorjsurenDet al. Small molecule inhibitors of the human apurinic\/apyrimidinic endonuclease 1 (APE1) . National Center for Biotechnology Information MD USA 27 ( 2010 )."},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.169128"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2009.12.006"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2008.02.071"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-010-0485-5"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.21666"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.2174\/187152008784220294"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-010-0484-6"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2008.2194"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-11-0107"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047462"},{"key":"e_1_3_2_49_1","unstructured":"Methoxyamine clinical trials ( 2013 ). www.clinicaltrials.gov\/ct2\/results?term=methoxyamine+&Search=Search"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon.09.31"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2013.5492"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27512"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-010-0488-2"},{"key":"e_1_3_2_54_1","unstructured":"ApeX Therapeutics Research ( 2013 ). http:\/\/apextherapeutics.com\/research ."},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.03.004"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003254"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-0821"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2007.115"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039588"},{"key":"e_1_3_2_60_1","unstructured":"Methotrexate in Metastatic Colorectal Cancer With MSH2 Deficiency (MESH) . http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00952016"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-2836"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.50.33811"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1307"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-11-0303"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2008.2"},{"key":"e_1_3_2_66_1","first-page":"559","volume-title":"New Research Directions in DNA Repair.","author":"Barakat KH","year":"2013","unstructured":"Barakat KH , TuszynskiJA . Nucleotide excision repair inhibitors: still a long way to go . In:New Research Directions in DNA Repair.ChenC (Ed.). InTech , AZ, USA , 559 \u2013 576 ( 2013 )."},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051329"},{"key":"e_1_3_2_68_1","unstructured":"UCN-01 clinical trials ( 2013 ). www.clinicaltrials.gov\/ct2\/results?term=UCN-01&pg=1 ."},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(01)00835-8"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-10-0263"},{"key":"e_1_3_2_71_1","unstructured":"Trabectedin clinical trials ( 2013 ). www.clinicaltrials.gov\/ct2\/results?term=trabectedin+&Search=Search ."},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks818"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-248"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks270"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01298-10"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.13.2.18872"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgq064"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2342"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201005110"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.287441"},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm401333u"},{"key":"e_1_3_2_82_1","first-page":"467","volume-title":"New Research Directions in DNA Repair.","author":"Renodon-Cornire A","year":"2013","unstructured":"Renodon-Cornire A , WeigelP , LeM , FleuryF . New potential therapeutic approaches by targeting Rad51-dependent homologous recombination . In:New Research Directions in DNA Repair.ChenC (Ed.). InTech , AZ, USA , 467 \u2013 488 ( 2013 )."},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.18.12748"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks353"},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2011.10.008"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.3109\/10409238.2011.578612"},{"key":"e_1_3_2_87_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-090308-173656"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2761.2010.01183.x"},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12192-010-0191-0"},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.2174\/187152008785914824"},{"key":"e_1_3_2_91_1","doi-asserted-by":"crossref","unstructured":"Meek K DangV Lees-MillerSP . Chapter 2 DNA-PK . 99 33 \u2013 58 ( 2008 ).","DOI":"10.1016\/S0065-2776(08)00602-0"},{"key":"e_1_3_2_92_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208332"},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2008.3"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-384999-1.10008-3"},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2013.00005"},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072641"},{"key":"e_1_3_2_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.11.054"},{"key":"e_1_3_2_98_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-011-1662-4"},{"key":"e_1_3_2_99_1","doi-asserted-by":"publisher","DOI":"10.1593\/neo.111512"},{"key":"e_1_3_2_100_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-1805"},{"key":"e_1_3_2_101_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-6636"},{"key":"e_1_3_2_102_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21204"},{"key":"e_1_3_2_103_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aet208"},{"key":"e_1_3_2_104_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt409"},{"key":"e_1_3_2_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-384999-1.10013-7"},{"key":"e_1_3_2_106_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/423713"},{"key":"e_1_3_2_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2013.04.007"},{"key":"e_1_3_2_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2011.06.004"},{"key":"e_1_3_2_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2013.04.020"},{"key":"e_1_3_2_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrfmmm.2006.06.007"},{"key":"e_1_3_2_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2007.04.005"},{"key":"e_1_3_2_112_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-013-1474-2"},{"issue":"1","key":"e_1_3_2_113_1","first-page":"53","article-title":"The antioxidant effects of the flavonoids rutin and quercetin inhibit oxaliplatin-induced chronic painful peripheral neuropathy","volume":"9","author":"Azevedo MI","year":"2013","unstructured":"Azevedo MI , PereiraAF , NogueiraRBet al. The antioxidant effects of the flavonoids rutin and quercetin inhibit oxaliplatin-induced chronic painful peripheral neuropathy . Mol. Pain9 ( 1 ), 53 ( 2013 ).","journal-title":"Mol. Pain"},{"key":"e_1_3_2_114_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0523-07.2007"},{"key":"e_1_3_2_115_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-1173"},{"key":"e_1_3_2_116_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054161"},{"key":"e_1_3_2_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2006.04.025"},{"key":"e_1_3_2_118_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-013-2306-7"},{"key":"e_1_3_2_119_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-013-1981-6"},{"key":"e_1_3_2_120_1","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000000002"},{"key":"e_1_3_2_121_1","unstructured":"Genentech & Inotek Enter into Exclusive Global Strategic Alliance for the Discovery Development and Commercialization of PARP Inhibitors for Cancer (2006) . www.gene.com\/media\/press-releases\/9907\/2006-07-25\/genentech-inotek-enter-into-exclusive-gl"},{"key":"e_1_3_2_122_1","unstructured":"Tracon Pharma Programs ( 2013 ). www.traconpharma.com\/progrms.php"},{"key":"e_1_3_2_123_1","unstructured":"Sentinel Oncology R&D Programmes ( 2013 ). www.sentineloncology.com\/pipeline"},{"key":"e_1_3_2_124_1","unstructured":"Allison M . Haseltine\u2019s DNA repair company steps out (2007) . www.xconomy.com\/boston\/2007\/12\/07\/haseltines-dna-repair-company-steps-out\/"},{"key":"e_1_3_2_125_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0312-206"},{"key":"e_1_3_2_126_1","unstructured":"Ubiquitination: labelling the proteins (2008) . www.sebiology.org\/publications\/Bulletin\/March08\/Ubiquitination.html?"},{"key":"e_1_3_2_127_1","first-page":"1","volume-title":"Paving the Way for Personalized Medicine. FDA\u2019s Role in a new Era of Medical Product Development.","author":"US FDA","year":"2013","unstructured":"US FDA . Paving the Way for Personalized Medicine. FDA\u2019s Role in a new Era of Medical Product Development.US Department of Health and Human Services , DC, USA , 1 \u2013 61 ( 2013 )."},{"key":"e_1_3_2_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-384999-1.10012-5"},{"key":"e_1_3_2_129_1","unstructured":"About Foundation Medicine ( 2013 ). www.foundationmedicine.com\/about.php"},{"key":"e_1_3_2_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.03.006"},{"key":"e_1_3_2_131_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq1087"},{"key":"e_1_3_2_132_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-13-0240"},{"issue":"203","key":"e_1_3_2_133_1","first-page":"1","article-title":"Emergence of rationally designed therapeutic strategies for breast cancer targeting DNA repair mechanisms","volume":"12","author":"Rowe BP","year":"2010","unstructured":"Rowe BP , GlazerPM . Emergence of rationally designed therapeutic strategies for breast cancer targeting DNA repair mechanisms . Breast Cancer Res.12 ( 203 ), 1 \u2013 11 ( 2010 ).","journal-title":"Breast Cancer Res."},{"key":"e_1_3_2_134_1","doi-asserted-by":"publisher","DOI":"10.2174\/156652410792630599"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon.14.60","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T02:43:35Z","timestamp":1719110615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon.14.60"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":132,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["10.2217\/fon.14.60"],"URL":"https:\/\/doi.org\/10.2217\/fon.14.60","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-06-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}